Bluejay Diagnostics earnings were -$20.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest BJDX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$14.7M, up 888.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BJDX reported annual earnings of -$20.9M, with 110.4% growth.
Bluejay Diagnostics Earnings Reports & History FAQ
What were Bluejay Diagnostics's earnings last quarter?
Bluejay Diagnostics (NASDAQ: BJDX) reported Q4 2024 earnings per share (EPS) of -$23.19, up 96.75% year over year. Total BJDX earnings for the quarter were -$14.66 million. In the same quarter last year, Bluejay Diagnostics's earnings per share (EPS) was -$712.48.
Is Bluejay Diagnostics profitable or losing money?
As of the last Bluejay Diagnostics earnings report, Bluejay Diagnostics is currently losing money. Bluejay Diagnostics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$7.72 million, a 22.46% decrease year over year.
What was BJDX's earnings growth in the past year?
As of Bluejay Diagnostics's earnings date in Q2 2025, Bluejay Diagnostics's earnings has grown year over year. BJDX earnings in the past year totalled -$20.94 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.